Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17827
Title: The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.
Austin Authors: Ng Tang Fui, Mark ;Hoermann, Rudolf;Zajac, Jeffrey D ;Grossmann, Mathis 
Affiliation: Medicine (University of Melbourne)
Endocrinology
Issue Date: Oct-2017
Date: 2017-06-27
Publication information: Clinical Endocrinology 2017; 87(4): 336-343
Abstract: Testosterone treatment in obese dieting men augments the diet-associated loss of fat mass, but protects against loss of lean mass. We assessed whether body composition changes are maintained following withdrawal of testosterone treatment. We conducted a prespecified double-blind randomized placebo-controlled observational follow-up study of a randomized controlled trial (RCT). Participants were men with baseline obesity (body mass index >30 kg/m2 ) and a repeated total testosterone level <12 nmol/L, previously enrolled in a 56-week testosterone treatment trial combined with a weight loss programme. Main outcome measures were mean adjusted differences (MAD) (95% confidence interval), in body composition between testosterone- and placebo-treated men at the end of the observation period. Of the 100 randomized men, 82 completed the RCT and 64 the subsequent observational study. Median [IQR] observation time after completion of the RCT was 82 weeks [74; 90] in men previously receiving testosterone (cases) and 81 weeks [67;91] in men previously receiving placebo (controls), P=.51. At the end of the RCT, while losing similar amounts of weight, cases had, compared to controls, lost more fat mass, MAD -2.9 kg (-5.7, -0.2), P=.04, but had lost less lean mass MAD 3.4 kg (1.3, 5.5), P=.002. At the end of the observation period, the former between-group differences in fat mass, MAD -0.8 kg (-3.6, 2.0), P=1.0, in lean mass, MAD -1.3 kg (-3.0, 0.5), P=.39, and in appendicular lean mass, MAD -0.1 kg/m2 (-0.3, 0.1), P=.45, were no longer apparent. During observation, cases lost more lean mass, MAD -3.7 kg (-5.5, -1.9), P=.0005, and appendicular lean mass, MAD -0.5 kg/m2 (-0.8, -0.3), P<.0001 compared to controls. The favourable effects of testosterone on body composition in men subjected to a concomitant weight loss programme were not maintained at 82 weeks after testosterone treatment cessation.
URI: https://ahro.austin.org.au/austinjspui/handle/1/17827
DOI: 10.1111/cen.13385
ORCID: 0000-0001-8261-3457
Journal: Clinical Endocrinology
PubMed URL: 28561278
Type: Journal Article
Subjects: fat mass
lean mass
obesity
testosterone
Appears in Collections:Journal articles

Show full item record

Page view(s)

34
checked on Jul 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.